NCT03328117View on ClinicalTrials.gov

A Study to Investigate the Effects of Imatinib on Pulmonary Vascular Dysfunction in a Human Model of Lung Injury

PHASE1CompletedINTERVENTIONAL

Enrollment

47

Participants

Timeline

Start Date

November 13, 2017

Primary Completion Date

March 5, 2018

Study Completion Date

March 5, 2018

Conditions

Acute Lung Injury

Interventions

DRUG

Imatinib

Over-encapsulated 100 mg imatinib mesilate tablets

DRUG

Placebo oral capsule

Matching placebo oral capsule

Trial Locations (1)

Unknown

PAREXEL Early Phase Clinical Unit, London

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Parexel

INDUSTRY

lead

Exvastat Ltd.

INDUSTRY